janiecbros Azenta ( NASDAQ: AZTA ) said it has received US regulatory approval and launched a long-read Whole Genome Sequencing, or WGS, test for clinical applications. The test uses PacBio’s ( PACB ) Revio sequencer and is performed within Azenta’s GENEWIZ genomics laboratory. “The test.
